Agios Pharmaceuticals, Inc. Financial Ratios — AGIO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-12.13	-23.3	-15.44	-25.82	-38.2	-51.02	-46.99	-47.05	-37.55	140.11	-17.32	-32.36	51.82	-27.89
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-159.95	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-32.19	- -
Gross Margin (%)	100	100	100	100	100	100	100	98.52	- -	- -	- -	88.03	89.26	88.59	88.26
EBITDA Margin (%)	-72.49	-86.9	-146.56	-80.73	-195.13	-279.4	-730.89	-376.44	- -	- -	- -	-2,671.93	-1,434.83	-1,150.98	-864.28
Operating Margin (%)	-76.16	-91.59	-152.2	-82.83	-200.78	-287.57	-745.84	-384.03	- -	- -	- -	-2,732.07	-1,459.52	-1,166.47	-873.87
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-48.96	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-75.56	-91.32	-151.98	-82.51	-199.14	-283.97	-731.6	-366.61	- -	- -	- -	-1,627.82	-1,312.63	1,967.15	-765.89
Profit Margin (%)	-108.56	-80.07	-154.25	-81.86	-199.14	-283.97	-731.6	-366.61	- -	- -	- -	-1,627.82	-1,312.63	1,845.92	-764.01
Net Income to Common Margin (%)	-122.75	-108.71	-170.54	-81.86	-199.14	-283.97	-731.6	-366.61	- -	- -	- -	-1,627.82	-1,312.63	1,845.92	-764.01
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.16	- -
Dvd Payout Ratio (%)	11.56	26.34	9.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	114	105	97	86	72	57	40
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	7	7	11	14	15	17	18
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	107	98	86	72	57	40	22
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.37	-0.32	-0.26	-0.23	-0.19	-0.14	-0.09
Net Debt/EBITDA	7.43	4.18	1.91	0.27	0.62	0.82	0.33	0.2	0.26	0.39	0.55	0.37	0.23	0.18	0.19
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.36	-0.31	-0.26	-0.22	-0.18	-0.13	-0.09
Net Debt/EBIT	7.07	3.97	1.84	0.26	0.6	0.8	0.32	0.19	0.26	0.38	0.54	0.36	0.23	0.18	0.19
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-18.29	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-19.08	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-18.84	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	18	- -	- -	- -	- -	- -
Common Equity/Total Assets	-27.73	-54.04	-56.37	-33.93	-67.76	-78.03	-129.89	-128.67	-170.2	-216.12	-16.6	-37.98	-87.78	-8.95	-43.29
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	16.67	24.48	6.65	6.54	7.03	2.61	1.83
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-7.61	-5.63	-60.69	-18.71	-7.59	-43.77	-4.18
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	11.98	11.46	5.98	5.81	6.08	2.42	1.68
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	17.75	26.33	7.52	7.78	8.88	3.7	3.37
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-8.1	-6.05	-68.57	-22.26	-9.59	-62.04	-7.71
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	12.76	12.33	6.75	6.92	7.68	3.43	3.1
Net Debt to Equity	-186.35	-207.98	-54.43	-3.31	-20.79	-44.83	-27.36	-10.25	-12.64	-31.9	-15.72	-12.65	-10.88	-4.95	-7.47
Net Debt/Capital (%)	211.35	184.78	38.69	7.75	20.14	24.97	11.4	6	5.46	6.83	58.92	26.57	10.52	45.36	14.6
EBITDA	-16	-22	-37	-53	-115	-195	-314	-355	-308	-326	-369	-380	-385	-420	-467
EBITDA-CapEx	-18	-23	-39	-55	-136	-205	-319	-362	-320	-340	-375	-385	-403	-422	-481
Operating Income (Loss)	-17	-23	-39	-54	-119	-201	-321	-362	-316	-336	-378	-389	-391	-426	-472

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.72	3.64	4.52	5.6	5.99	6.12	4.47	6.26	6.08	6.07	17.05	12.5	11.43	11.01	10.39
Current Ratio	3.96	3.71	4.6	5.89	6.38	6.33	4.69	6.56	6.59	6.74	17.79	13.3	12.27	11.9	11.46
Quick Ratio	3.72	3.64	4.53	5.81	6.21	6.22	4.5	6.37	6.25	6.07	17.12	12.54	11.47	11.06	10.52
CFO/Avg Current Liab	- -	-1.19	-1.57	-1.21	-1.35	0.55	-3.11	-3.23	-3.98	-3.11	-5.28	-5.05	-4.53	-5.23	-4.57
Common Equity/Total Assets	-27.73	-54.04	-56.37	-33.93	-67.76	-78.03	-129.89	-128.67	-170.2	-216.12	-16.6	-37.98	-87.78	-8.95	-43.29
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	16.67	24.48	6.65	6.54	7.03	2.61	1.83
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-7.61	-5.63	-60.69	-18.71	-7.59	-43.77	-4.18
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	11.98	11.46	5.98	5.81	6.08	2.42	1.68
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	17.75	26.33	7.52	7.78	8.88	3.7	3.37
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-8.1	-6.05	-68.57	-22.26	-9.59	-62.04	-7.71
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	12.76	12.33	6.75	6.92	7.68	3.43	3.1
CFO/Total Liabilities	-11.59	-53.21	-80.89	-87.88	-102.67	14.8	-119.4	-178.11	-148.12	-64.12	-279.44	-224.42	-234.79	-318.91	-358.25
CFO/CapEx	-7.98	-33.59	-43.59	-26.78	-3.82	3.89	-61.65	-43.58	-30.81	-20.61	-70.95	-63.4	-16	-231.36	-26.05
Altman's Z-Score	0.32	-0.29	2.67	33.53	18.53	2.62	3.9	6.94	4.01	0.39	7.92	5.88	4.3	8.85	8.12

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	107.34	18.76	8.03	10.66	10.05	13.38	- -	- -	- -	12.91	10.69	10.55	7.36
Days Sales Outstanding	- -	- -	3.4	19.46	45.43	34.24	36.3	27.29	- -	- -	- -	28.27	34.13	34.6	49.61
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	3.22	0.32	0.25	- -	0.4	0.21	0.18	0.21
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	113.52	1,136.29	1,433.26	- -	909.5	1,746.32	2,045.93	1,741.19
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.11	0.39	0.51	-0.85	0.58	0.95	0.96	0.67
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	3,273.64	933.17	710.84	-427.43	632.13	384.87	379.55	548.3
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-3,132.83	- -	- -	- -	305.65	1,395.58	1,700.97	1,242.49
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-86.24	- -	- -	- -	-881.23	-1,712.2	-2,011.33	-1,691.58
Inventories	- -	- -	- -	- -	- -	- -	- -	1	7	15	- -	8	19	28	33
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	1	7	13	- -	8	18	25	30
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	1	1	3	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	369	3,772	2,430	1,633	2,663	2,648	2,865	2,990	1,987	1,538	1,239	1,867	1,578
- Cash & Cash Equivalents	118	91	72	14	72	161	103	71	81	127	203	139	88	76	89
+ Preferred Equity and Hybrid Capital	116	116	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	114	105	97	86	72	57	40
Enterprise Value	-63	-12	202	3,430	2,113	1,091	2,239	2,062	2,414	2,522	1,064	841	534	1,030	764
Total Capital	62	42	-113	-167	-285	-483	-798	-1,105	-1,402	-1,738	-142	-385	-751	-92	-521
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-8.1	-6.05	-68.57	-22.26	-9.59	-62.04	-7.71
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.05	0.04	0.09	0.1	0.13	0.06	0.05
EV/Sales	- -	- -	7.92	52.48	35.74	15.62	52.07	21.85	- -	- -	- -	59.06	19.92	28.22	14.14
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	28.3	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	22.51	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	369	3,772	2,430	1,633	2,663	2,648	2,865	2,990	1,987	1,538	1,239	1,902	1,578
Diluted Enterprise Value	-2	25	298	3,758	2,358	1,472	2,561	2,577	2,897	2,967	1,881	1,485	1,223	1,883	1,529
EV per Share	- -	- -	13.13	101.88	56.45	27.89	48.07	35.92	40.23	36.55	17.6	15.35	9.6	18.13	13.17
TTM Sales	22	25	26	65	59	70	43	94	- -	- -	- -	14	27	36	54
TTM EBITDA	-16	-22	-37	-53	-115	-195	-314	-355	-308	-326	-369	-380	-385	-420	-467
TTM Operating Income	-17	-23	-39	-54	-119	-201	-321	-362	-316	-336	-378	-389	-391	-426	-472
TTM Cash Flow to Firm	-15	-50	-56	-59	-77	39	-285	-304	-371	-273	-407	-309	-296	-390	-373
TTM Free Cash Flow to Firm	-13	-48	-55	-57	-57	48	-281	-297	-359	-259	-402	-305	-278	-388	-359

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-6.7	-66.02	-42.79	33.68	-9.49	-8.9	-7.99	-10.81	-4.95	-5.05	-4.47	-4.9	-4.4
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-63	-12	202	3,430	2,113	1,091	2,239	2,062	2,414	2,522	1,064	841	534	1,030	764
Low Price	- -	- -	15.77	21.7	48	33.5	39.24	41.63	28.36	27.77	29.21	16.75	19.8	20.96	22.24
EV/Sales	- -	- -	7.92	52.48	35.74	15.62	52.07	21.85	- -	- -	- -	59.06	19.92	28.22	14.14
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.24	- -	- -	2.77	- -
Price/Earnings Average	- -	- -	-8.79	-32.67	-30.37	-9.28	-8.22	-12.73	-6.94	-9.26	1.83	-6.39	-3.96	3.29	-4.79
Price/Earnings High	- -	- -	-11.88	-78.27	-44.14	-13.35	-10.77	-16.56	-10.05	-11.96	2.34	-8.3	-4.99	5.28	-6.46
Price/Earnings Low	- -	- -	-5.58	-13.65	-15.26	-6.6	-5.81	-6.91	-4.14	-5.85	1.1	-3.96	-3.13	1.77	-3.12
Price/Book Value	- -	- -	-3.26	-22.6	-8.54	-3.38	-3.34	-2.4	-1.89	-1.62	-8.32	-3.27	-1.51	-12.54	-2.81
Price/Book Value Average	- -	- -	-3.38	-10.47	-12.56	-3.81	-3.24	-3.99	-1.88	-1.64	-12.27	-3.15	-1.7	-14.87	-3.52
Price/Book Value High	- -	- -	-4.57	-25.09	-18.26	-5.49	-4.25	-5.19	-2.73	-2.12	-15.74	-4.09	-2.14	-23.88	-4.75
Price/Book Value Low	- -	- -	-2.14	-4.38	-6.31	-2.71	-2.29	-2.16	-1.12	-1.04	-7.4	-1.95	-1.34	-8	-2.3
Price/Tangible Book Value	- -	- -	2.81	8.89	7.04	4.55	7.09	3.85	4.47	7.48	1.54	1.4	1.53	1.21	1.32
Price/Tangible Book Value Average	- -	- -	2.91	4.12	10.36	5.14	6.89	6.41	4.46	7.59	2.27	1.35	1.72	1.44	1.66
Price/Tangible Book Value High	- -	- -	3.94	9.87	15.06	7.39	9.02	8.34	6.46	9.8	2.91	1.75	2.17	2.31	2.24
Price/Tangible Book Value Low	- -	- -	1.85	1.72	5.21	3.66	4.87	3.48	2.66	4.8	1.37	0.83	1.36	0.77	1.08
Price/Sales	- -	- -	14.45	57.71	41.1	23.36	61.92	28.05	- -	- -	- -	108.04	46.21	51.15	29.21
Price/Sales Average	- -	- -	15	26.74	60.48	26.35	60.16	46.66	- -	- -	- -	104.04	52.02	60.66	36.58
Price/Sales High	- -	- -	20.27	64.08	87.91	37.92	78.78	60.73	- -	- -	- -	135.13	65.48	97.4	49.36
Price/Sales Low	- -	- -	9.52	11.18	30.39	18.75	42.5	25.32	- -	- -	- -	64.45	41.07	32.62	23.86
Price/Cash Flow	- -	- -	-6.55	-63.55	-31.58	42.34	-9.34	-8.7	-7.73	-10.28	-4.88	-4.97	-4.19	-4.79	-4.23
Price/Cash Flow Average	- -	- -	-6.79	-29.45	-46.47	47.76	-9.07	-14.47	-7.7	-10.43	-7.19	-4.79	-4.71	-5.68	-5.3
Price/Cash Flow High	- -	- -	-9.18	-70.56	-67.54	68.73	-11.88	-18.83	-11.16	-13.47	-9.22	-6.22	-5.93	-9.12	-7.15
Price/Cash Flow Low	- -	- -	-4.31	-12.31	-23.35	33.99	-6.41	-7.85	-4.59	-6.59	-4.33	-2.97	-3.72	-3.05	-3.46
Price/Free Cash Flow Average	- -	- -	-6.95	-30.59	-62.97	37.99	-9.22	-14.81	-7.96	-10.96	-7.29	-4.86	-5.03	-5.81	-5.51
Price/Free Cash Flow High	- -	- -	-9.4	-73.29	-91.52	54.67	-12.08	-19.27	-11.53	-14.15	-9.36	-6.32	-6.33	-9.33	-7.44
Price/Free Cash Flow Low	- -	- -	-4.41	-12.79	-31.64	27.04	-6.51	-8.04	-4.74	-6.93	-4.4	-3.01	-3.97	-3.13	-3.59
EV/Sales Average	- -	0.98	12.2	26.53	59.27	24.05	57.77	45.91	- -	- -	- -	100.27	51.41	60.13	35.67
EV/Sales High	- -	0.98	17.47	63.86	86.69	35.62	76.39	59.98	- -	- -	- -	131.36	64.88	96.88	48.45
EV/Sales Low	- -	0.98	6.71	10.96	29.18	16.45	40.12	24.58	- -	- -	- -	60.68	40.47	32.1	22.96
EV/EBITDA Average	0.11	-1.13	-8.32	-32.86	-30.37	-8.61	-7.9	-12.2	-9.37	-9.23	-7.65	-3.75	-3.58	-5.22	-4.13
EV/EBITDA High	0.11	-1.13	-11.92	-79.1	-44.43	-12.75	-10.45	-15.93	-13.53	-11.94	-9.89	-4.92	-4.52	-8.42	-5.61
EV/EBITDA Low	0.11	-1.13	-4.58	-13.58	-14.95	-5.89	-5.49	-6.53	-5.63	-5.81	-4.5	-2.27	-2.82	-2.79	-2.66
EV/EBIT Average	0.1	-1.07	-8.01	-32.03	-29.52	-8.36	-7.75	-11.96	-9.13	-8.96	-7.46	-3.67	-3.52	-5.15	-4.08
EV/EBIT High	0.1	-1.07	-11.48	-77.1	-43.18	-12.39	-10.24	-15.62	-13.18	-11.59	-9.65	-4.81	-4.44	-8.31	-5.54
EV/EBIT Low	0.1	-1.07	-4.41	-13.24	-14.53	-5.72	-5.38	-6.4	-5.48	-5.64	-4.39	-2.22	-2.77	-2.75	-2.63
Last Price	- -	- -	23.95	112.04	64.92	41.73	57.17	46.11	47.75	43.33	32.87	28.08	22.27	32.86	27.22
High Price	- -	- -	33.59	124.39	138.85	67.74	72.73	99.82	68.94	56.74	62.16	35.12	31.56	62.58	46
Enterprise Value Average	-2	25	312	1,734	3,504	1,681	2,485	4,334	2,887	3,010	2,823	1,428	1,379	2,195	1,927
Enterprise Value High	-2	25	446	4,174	5,125	2,490	3,286	5,661	4,169	3,893	3,651	1,871	1,740	3,536	2,618
Enterprise Value Low	-2	25	172	717	1,725	1,150	1,725	2,320	1,734	1,894	1,660	864	1,085	1,171	1,240

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	30	30	31	37	38	42	49	58	68	69	54	55	56	57	58
Diluted Weighted Avg Shares	23	23	15	34	37	39	47	57	60	69	60	55	56	58	58
Basic Weighted Avg Shares	23	23	15	34	37	39	47	57	60	69	60	55	56	57	58
Revenue per Share	0.93	1.07	1.66	1.94	1.58	1.79	0.92	1.64	- -	- -	- -	0.26	0.48	0.64	0.93
EBITDA per Share	-0.68	-0.93	-2.43	-1.57	-3.08	-4.99	-6.75	-6.19	-5.14	-4.73	-6.11	-6.94	-6.92	-7.39	-8.05
Operating Income per Share	-0.71	-0.98	-2.52	-1.61	-3.17	-5.14	-6.89	-6.31	-5.27	-4.87	-6.26	-7.1	-7.03	-7.49	-8.14
Basic EPS, GAAP	-1.15	-1.17	-2.83	-1.59	-3.15	-5.07	-6.75	-6.03	-6.86	-4.74	26.55	-4.23	-6.33	11.86	-7.12
Basic EPS from Cont Ops	-1.01	-0.86	-2.56	-1.59	-3.15	-5.07	-6.75	-6.03	-5.02	-4.77	-5.9	-4.23	-6.33	11.86	-7.12
Diluted EPS, GAAP	-1.15	-1.17	-2.83	-1.59	-3.15	-5.07	-6.75	-6.03	-6.86	-4.74	26.55	-4.23	-6.33	11.64	-7.12
Diluted EPS from Cont Ops	-1.01	-0.86	-2.56	-1.59	-3.15	-5.07	-6.75	-6.03	-5.02	-4.77	-5.9	-4.23	-6.33	11.64	-7.12
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.65	-2.12	-3.66	-1.76	-2.06	0.99	-6.12	-5.3	-6.18	-4.21	-6.74	-5.65	-5.32	-6.86	-6.43
Free Cash Flow per Basic Share	-0.73	-2.18	-3.74	-1.83	-2.59	0.73	-6.22	-5.42	-6.38	-4.42	-6.83	-5.74	-5.65	-6.89	-6.68
Cash & Equivalents per Share	7.66	5.47	10.82	10.16	8.47	13.84	9.1	10.19	9.42	8.3	16.87	14.29	13.96	15.73	14.74
Book Value per Share	-2.31	-3.17	-7.36	-4.96	-7.6	-12.35	-17.13	-19.24	-25.27	-26.72	-3.95	-8.59	-14.78	-2.62	-9.69
Tangible Book Value per Share	-2.26	-3.08	8.53	12.6	9.22	9.16	8.06	11.97	10.68	5.79	21.37	20.09	14.57	27.13	20.58

Agios Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)